

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | nuclear pore complex assembly (GO:0051292) | 5.72597930 |
| 2 | bile acid and bile salt transport (GO:0015721) | 5.12774936 |
| 3 | tryptophan metabolic process (GO:0006568) | 5.00821841 |
| 4 | nuclear pore organization (GO:0006999) | 4.67669457 |
| 5 | indole-containing compound catabolic process (GO:0042436) | 4.56944102 |
| 6 | indolalkylamine catabolic process (GO:0046218) | 4.56944102 |
| 7 | tryptophan catabolic process (GO:0006569) | 4.56944102 |
| 8 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.56310599 |
| 9 | protein carboxylation (GO:0018214) | 4.56310599 |
| 10 | aromatic amino acid family catabolic process (GO:0009074) | 4.54019464 |
| 11 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.51126227 |
| 12 | L-phenylalanine catabolic process (GO:0006559) | 4.51126227 |
| 13 | complement activation, alternative pathway (GO:0006957) | 4.48735296 |
| 14 | urea cycle (GO:0000050) | 4.42472320 |
| 15 | urea metabolic process (GO:0019627) | 4.42472320 |
| 16 | regulation of protein activation cascade (GO:2000257) | 4.25608873 |
| 17 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.24962890 |
| 18 | kynurenine metabolic process (GO:0070189) | 4.23792209 |
| 19 | pore complex assembly (GO:0046931) | 4.15596464 |
| 20 | tyrosine metabolic process (GO:0006570) | 4.09719306 |
| 21 | L-phenylalanine metabolic process (GO:0006558) | 4.02704334 |
| 22 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.02704334 |
| 23 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.02652512 |
| 24 | regulation of complement activation (GO:0030449) | 4.01257568 |
| 25 | high-density lipoprotein particle remodeling (GO:0034375) | 3.96415201 |
| 26 | phospholipid homeostasis (GO:0055091) | 3.87762434 |
| 27 | homocysteine metabolic process (GO:0050667) | 3.80028990 |
| 28 | negative regulation of fibrinolysis (GO:0051918) | 3.78931128 |
| 29 | embryonic process involved in female pregnancy (GO:0060136) | 3.78074168 |
| 30 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.74693826 |
| 31 | detection of molecule of bacterial origin (GO:0032490) | 3.73551538 |
| 32 | nitrogen cycle metabolic process (GO:0071941) | 3.72765865 |
| 33 | serine family amino acid catabolic process (GO:0009071) | 3.72518892 |
| 34 | bile acid biosynthetic process (GO:0006699) | 3.68259456 |
| 35 | phospholipid efflux (GO:0033700) | 3.58599738 |
| 36 | indolalkylamine metabolic process (GO:0006586) | 3.54637592 |
| 37 | regulation of triglyceride catabolic process (GO:0010896) | 3.54387626 |
| 38 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.48497529 |
| 39 | regulation of fibrinolysis (GO:0051917) | 3.48112057 |
| 40 | reverse cholesterol transport (GO:0043691) | 3.48008575 |
| 41 | alpha-linolenic acid metabolic process (GO:0036109) | 3.44653732 |
| 42 | regulation of RNA export from nucleus (GO:0046831) | 3.44483424 |
| 43 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 3.41867247 |
| 44 | cellular extravasation (GO:0045123) | 3.35622027 |
| 45 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.35326269 |
| 46 | positive regulation by symbiont of host defense response (GO:0052509) | 3.33104606 |
| 47 | modulation by symbiont of host defense response (GO:0052031) | 3.33104606 |
| 48 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.33104606 |
| 49 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.33104606 |
| 50 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.33104606 |
| 51 | modulation by symbiont of host immune response (GO:0052553) | 3.33104606 |
| 52 | dosage compensation (GO:0007549) | 3.24832022 |
| 53 | macrophage activation involved in immune response (GO:0002281) | 3.24320218 |
| 54 | negative regulation of cell killing (GO:0031342) | 3.22262691 |
| 55 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.22262691 |
| 56 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.20997830 |
| 57 | regulation of gamma-delta T cell activation (GO:0046643) | 3.20735320 |
| 58 | aromatic amino acid family metabolic process (GO:0009072) | 3.20564361 |
| 59 | pantothenate metabolic process (GO:0015939) | 3.20236313 |
| 60 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.19887607 |
| 61 | protein-lipid complex remodeling (GO:0034368) | 3.19643427 |
| 62 | macromolecular complex remodeling (GO:0034367) | 3.19643427 |
| 63 | plasma lipoprotein particle remodeling (GO:0034369) | 3.19643427 |
| 64 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.17899844 |
| 65 | bile acid metabolic process (GO:0008206) | 3.17343203 |
| 66 | hypotonic response (GO:0006971) | 3.16694645 |
| 67 | regulation of nucleobase-containing compound transport (GO:0032239) | 3.15634877 |
| 68 | cholesterol efflux (GO:0033344) | 3.14495400 |
| 69 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.13386823 |
| 70 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.13164239 |
| 71 | plasma lipoprotein particle assembly (GO:0034377) | 3.12748300 |
| 72 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.11654076 |
| 73 | regulation of necroptotic process (GO:0060544) | 3.11402057 |
| 74 | amino-acid betaine metabolic process (GO:0006577) | 3.11116486 |
| 75 | mitotic sister chromatid cohesion (GO:0007064) | 3.10979520 |
| 76 | imidazole-containing compound metabolic process (GO:0052803) | 3.10847144 |
| 77 | histone H3-K9 demethylation (GO:0033169) | 3.09591433 |
| 78 | regulation of cholesterol esterification (GO:0010872) | 3.07145739 |
| 79 | glycine metabolic process (GO:0006544) | 3.06537725 |
| 80 | B cell receptor signaling pathway (GO:0050853) | 3.06535136 |
| 81 | positive regulation of respiratory burst (GO:0060267) | 3.06233280 |
| 82 | regulation of histone H3-K27 methylation (GO:0061085) | 3.05364970 |
| 83 | histone lysine demethylation (GO:0070076) | 3.04379647 |
| 84 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.04269078 |
| 85 | acylglycerol homeostasis (GO:0055090) | 3.03010072 |
| 86 | triglyceride homeostasis (GO:0070328) | 3.03010072 |
| 87 | response to muramyl dipeptide (GO:0032495) | 3.02665784 |
| 88 | response to peptidoglycan (GO:0032494) | 3.01225967 |
| 89 | negative regulation of sterol transport (GO:0032372) | 2.99970209 |
| 90 | negative regulation of cholesterol transport (GO:0032375) | 2.99970209 |
| 91 | acute-phase response (GO:0006953) | 2.98802960 |
| 92 | amine catabolic process (GO:0009310) | 2.98350592 |
| 93 | cellular biogenic amine catabolic process (GO:0042402) | 2.98350592 |
| 94 | hepatocyte apoptotic process (GO:0097284) | 2.97108748 |
| 95 | glyoxylate metabolic process (GO:0046487) | 2.96823835 |
| 96 | sulfur amino acid catabolic process (GO:0000098) | 2.95532673 |
| 97 | cellular glucuronidation (GO:0052695) | 2.95095781 |
| 98 | detection of external biotic stimulus (GO:0098581) | 2.94900955 |
| 99 | detection of other organism (GO:0098543) | 2.94770654 |
| 100 | cellular response to ethanol (GO:0071361) | 2.91254069 |
| 101 | histone demethylation (GO:0016577) | 2.91248258 |
| 102 | definitive hemopoiesis (GO:0060216) | 2.89792629 |
| 103 | positive regulation of lipid catabolic process (GO:0050996) | 2.89236724 |
| 104 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.87885232 |
| 105 | protein-lipid complex assembly (GO:0065005) | 2.85774401 |
| 106 | alpha-amino acid catabolic process (GO:1901606) | 2.83568064 |
| 107 | low-density lipoprotein particle remodeling (GO:0034374) | 2.82073719 |
| 108 | complement activation (GO:0006956) | 2.81957337 |
| 109 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.80735916 |
| 110 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.78882427 |
| 111 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.78882427 |
| 112 | plasma lipoprotein particle clearance (GO:0034381) | 2.78833237 |
| 113 | complement activation, classical pathway (GO:0006958) | 2.78693529 |
| 114 | germinal center formation (GO:0002467) | 2.78561793 |
| 115 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.75627994 |
| 116 | iron ion import (GO:0097286) | 2.75365429 |
| 117 | fibrinolysis (GO:0042730) | 2.75262448 |
| 118 | coenzyme A biosynthetic process (GO:0015937) | 2.74497904 |
| 119 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.72603963 |
| 120 | protein activation cascade (GO:0072376) | 2.70946310 |
| 121 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.70731201 |
| 122 | lipoprotein metabolic process (GO:0042157) | 2.69973561 |
| 123 | peptidyl-threonine phosphorylation (GO:0018107) | 2.69762317 |
| 124 | plasma lipoprotein particle organization (GO:0071827) | 2.69417932 |
| 125 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.69184814 |
| 126 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.67526374 |
| 127 | positive regulation of transcription from RNA polymerase III promoter (GO:0045945) | 2.64938713 |
| 128 | regulation of humoral immune response (GO:0002920) | 2.63611091 |
| 129 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.62118613 |
| 130 | peptidyl-threonine modification (GO:0018210) | 2.62052578 |
| 131 | pre-miRNA processing (GO:0031054) | 2.61753701 |
| 132 | cholesterol homeostasis (GO:0042632) | 2.61100384 |
| 133 | macrophage activation (GO:0042116) | 2.60495401 |
| 134 | sterol homeostasis (GO:0055092) | 2.60415017 |
| 135 | glutamate metabolic process (GO:0006536) | 2.60011733 |
| 136 | detection of biotic stimulus (GO:0009595) | 2.60000780 |
| 137 | indole-containing compound metabolic process (GO:0042430) | 2.59805136 |
| 138 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.59531122 |
| 139 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.59531122 |
| 140 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.59531122 |
| 141 | response to host (GO:0075136) | 2.58811529 |
| 142 | response to host defenses (GO:0052200) | 2.58811529 |
| 143 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.58811529 |
| 144 | negative regulation of lipase activity (GO:0060192) | 2.57256348 |
| 145 | thrombin receptor signaling pathway (GO:0070493) | 2.56732293 |
| 146 | protein-lipid complex subunit organization (GO:0071825) | 2.56551175 |
| 147 | interkinetic nuclear migration (GO:0022027) | 2.56396538 |
| 148 | arginine metabolic process (GO:0006525) | 2.55816124 |
| 149 | response to laminar fluid shear stress (GO:0034616) | 2.54687283 |
| 150 | histone H3-K36 demethylation (GO:0070544) | 2.54556589 |
| 151 | neutrophil mediated immunity (GO:0002446) | 2.53823979 |
| 152 | histone H3-K4 trimethylation (GO:0080182) | 2.53059701 |
| 153 | cysteine metabolic process (GO:0006534) | 2.52995053 |
| 154 | regulation of plasminogen activation (GO:0010755) | 2.52344874 |
| 155 | negative regulation of granulocyte differentiation (GO:0030853) | 2.50192647 |
| 156 | protein localization to endosome (GO:0036010) | 2.49880349 |
| 157 | negative regulation of protein activation cascade (GO:2000258) | 2.48601799 |
| 158 | cytolysis (GO:0019835) | 2.47906818 |
| 159 | negative regulation of necroptotic process (GO:0060546) | 2.47576090 |
| 160 | negative regulation of interleukin-12 production (GO:0032695) | 2.46604003 |
| 161 | protein dealkylation (GO:0008214) | 2.46085125 |
| 162 | protein demethylation (GO:0006482) | 2.46085125 |
| 163 | detection of bacterium (GO:0016045) | 2.45402690 |
| 164 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.45302494 |
| 165 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.45285259 |
| 166 | response to host immune response (GO:0052572) | 2.45271078 |
| 167 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.45271078 |
| 168 | cellular response to fluid shear stress (GO:0071498) | 2.44345345 |
| 169 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 2.43262858 |
| 170 | positive regulation of interferon-alpha production (GO:0032727) | 2.43246270 |
| 171 | peptidyl-lysine trimethylation (GO:0018023) | 2.42721813 |
| 172 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.42387802 |
| 173 | neutrophil activation involved in immune response (GO:0002283) | 2.41234894 |
| 174 | negative thymic T cell selection (GO:0045060) | 2.40019174 |
| 175 | positive T cell selection (GO:0043368) | 2.39885447 |
| 176 | positive regulation of granulocyte differentiation (GO:0030854) | 2.38724185 |
| 177 | embryonic camera-type eye morphogenesis (GO:0048596) | 2.37870856 |
| 178 | leukocyte aggregation (GO:0070486) | 2.36583485 |
| 179 | microglial cell activation (GO:0001774) | 2.34563349 |
| 180 | histone H3-K4 methylation (GO:0051568) | 2.34452247 |
| 181 | negative T cell selection (GO:0043383) | 2.34122743 |
| 182 | positive thymic T cell selection (GO:0045059) | 2.32163869 |
| 183 | response to interleukin-15 (GO:0070672) | 2.31434870 |
| 184 | negative regulation of T cell mediated immunity (GO:0002710) | 2.31430812 |
| 185 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.27484348 |
| 186 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.27356516 |
| 187 | megakaryocyte development (GO:0035855) | 2.25789316 |
| 188 | necrotic cell death (GO:0070265) | 2.23896887 |
| 189 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.23853784 |
| 190 | positive regulation of B cell differentiation (GO:0045579) | 2.22147092 |
| 191 | negative regulation of myotube differentiation (GO:0010832) | 2.22077457 |
| 192 | necroptotic process (GO:0070266) | 2.21657846 |
| 193 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.20672894 |
| 194 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.18794863 |
| 195 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.18725119 |
| 196 | T cell selection (GO:0045058) | 2.18644410 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.88103493 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.36376050 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.95133480 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.76676302 |
| 5 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.69249283 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.34550972 |
| 7 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.07598474 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.93808539 |
| 9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.93173386 |
| 10 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.71397694 |
| 11 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.51185237 |
| 12 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.48682428 |
| 13 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.38959971 |
| 14 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.35801493 |
| 15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.34806915 |
| 16 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.31540680 |
| 17 | GATA1_22025678_ChIP-Seq_K562_Human | 2.10276453 |
| 18 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.09205275 |
| 19 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.03823946 |
| 20 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.02430064 |
| 21 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.01477155 |
| 22 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.92729678 |
| 23 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.89693352 |
| 24 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.88541908 |
| 25 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.81860122 |
| 26 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.79449873 |
| 27 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.74680737 |
| 28 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.72859198 |
| 29 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.67606652 |
| 30 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.67135242 |
| 31 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.64116691 |
| 32 | TP53_16413492_ChIP-PET_HCT116_Human | 1.62909263 |
| 33 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.57944320 |
| 34 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.57232612 |
| 35 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.56066213 |
| 36 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.55474726 |
| 37 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.52603569 |
| 38 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.49889719 |
| 39 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.49451865 |
| 40 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.48973662 |
| 41 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.48973662 |
| 42 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.48751209 |
| 43 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.46509711 |
| 44 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.46450370 |
| 45 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.46272388 |
| 46 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.45828199 |
| 47 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.40105165 |
| 48 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.39204854 |
| 49 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.38260675 |
| 50 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.37796434 |
| 51 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.36043633 |
| 52 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.35718655 |
| 53 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.34655842 |
| 54 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.34390336 |
| 55 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.32616938 |
| 56 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.28850193 |
| 57 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.28326586 |
| 58 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.28020636 |
| 59 | UTX_26944678_Chip-Seq_JUKART_Human | 1.26602676 |
| 60 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.22878090 |
| 61 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.21571577 |
| 62 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.17904756 |
| 63 | GATA1_19941826_ChIP-Seq_K562_Human | 1.17346851 |
| 64 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.17105130 |
| 65 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.15780307 |
| 66 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.15221981 |
| 67 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.14839447 |
| 68 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.10172985 |
| 69 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.09233001 |
| 70 | RXR_22108803_ChIP-Seq_LS180_Human | 1.08759366 |
| 71 | MYC_22102868_ChIP-Seq_BL_Human | 1.08314226 |
| 72 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.08218132 |
| 73 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.07720833 |
| 74 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.07040989 |
| 75 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.06536211 |
| 76 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06434795 |
| 77 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.06012816 |
| 78 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.05522463 |
| 79 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.03996738 |
| 80 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.03571265 |
| 81 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.03536521 |
| 82 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.03475474 |
| 83 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.01634624 |
| 84 | * CHD1_26751641_Chip-Seq_LNCaP_Human | 1.01565918 |
| 85 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.01369722 |
| 86 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.00795393 |
| 87 | SPI1_23127762_ChIP-Seq_K562_Human | 1.00414268 |
| 88 | MYB_26560356_Chip-Seq_TH1_Human | 1.00268781 |
| 89 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.00175154 |
| 90 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.99596115 |
| 91 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.99400599 |
| 92 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.96726799 |
| 93 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.96102765 |
| 94 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.96091683 |
| 95 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.94757906 |
| 96 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.94742594 |
| 97 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.94009164 |
| 98 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.93832786 |
| 99 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.93592556 |
| 100 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.92976179 |
| 101 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.92907168 |
| 102 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92834004 |
| 103 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.92314000 |
| 104 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.91815644 |
| 105 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.91727769 |
| 106 | * MAF_26560356_Chip-Seq_TH2_Human | 0.91440355 |
| 107 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.91378794 |
| 108 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.90981626 |
| 109 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.90566052 |
| 110 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.90271145 |
| 111 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.89455852 |
| 112 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.88962681 |
| 113 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.88092475 |
| 114 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.87331752 |
| 115 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.86913246 |
| 116 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.85369088 |
| 117 | MAF_26560356_Chip-Seq_TH1_Human | 0.84894046 |
| 118 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.84586671 |
| 119 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.84326399 |
| 120 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.84277140 |
| 121 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.84050586 |
| 122 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.83629976 |
| 123 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 0.82900152 |
| 124 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.82667020 |
| 125 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.81538176 |
| 126 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.80646144 |
| 127 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.80218706 |
| 128 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.78202878 |
| 129 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.78109804 |
| 130 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.77875046 |
| 131 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.77043563 |
| 132 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.76670557 |
| 133 | GATA2_19941826_ChIP-Seq_K562_Human | 0.76238623 |
| 134 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.76025521 |
| 135 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.75881387 |
| 136 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.75737835 |
| 137 | MYB_26560356_Chip-Seq_TH2_Human | 0.75555727 |
| 138 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.74633485 |
| 139 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.74633485 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.56443585 |
| 2 | MP0010234_abnormal_vibrissa_follicle | 5.26982689 |
| 3 | MP0005360_urolithiasis | 4.89149846 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.43899334 |
| 5 | MP0005365_abnormal_bile_salt | 4.11293181 |
| 6 | MP0003252_abnormal_bile_duct | 3.74829067 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 2.80038125 |
| 8 | MP0002138_abnormal_hepatobiliary_system | 2.79598722 |
| 9 | MP0010329_abnormal_lipoprotein_level | 2.52294240 |
| 10 | MP0000569_abnormal_digit_pigmentation | 2.41769668 |
| 11 | MP0005451_abnormal_body_composition | 2.31594987 |
| 12 | MP0003724_increased_susceptibility_to | 2.17190843 |
| 13 | MP0003191_abnormal_cellular_cholesterol | 2.03115950 |
| 14 | MP0002166_altered_tumor_susceptibility | 1.97647871 |
| 15 | MP0003828_pulmonary_edema | 1.96850858 |
| 16 | MP0001835_abnormal_antigen_presentation | 1.93768815 |
| 17 | MP0009697_abnormal_copulation | 1.92452125 |
| 18 | MP0005409_darkened_coat_color | 1.88338281 |
| 19 | MP0003300_gastrointestinal_ulcer | 1.77613638 |
| 20 | MP0004185_abnormal_adipocyte_glucose | 1.77129597 |
| 21 | MP0000609_abnormal_liver_physiology | 1.69398592 |
| 22 | MP0010678_abnormal_skin_adnexa | 1.68115667 |
| 23 | MP0003656_abnormal_erythrocyte_physiolo | 1.66735524 |
| 24 | MP0003705_abnormal_hypodermis_morpholog | 1.66640351 |
| 25 | MP0005076_abnormal_cell_differentiation | 1.65185361 |
| 26 | MP0009840_abnormal_foam_cell | 1.63720900 |
| 27 | MP0002928_abnormal_bile_duct | 1.59734684 |
| 28 | MP0005464_abnormal_platelet_physiology | 1.57507098 |
| 29 | MP0002396_abnormal_hematopoietic_system | 1.56707455 |
| 30 | MP0004381_abnormal_hair_follicle | 1.56160428 |
| 31 | MP0008260_abnormal_autophagy | 1.52709532 |
| 32 | MP0004264_abnormal_extraembryonic_tissu | 1.51151138 |
| 33 | MP0010352_gastrointestinal_tract_polyps | 1.49569735 |
| 34 | MP0008057_abnormal_DNA_replication | 1.44878302 |
| 35 | MP0004808_abnormal_hematopoietic_stem | 1.40056595 |
| 36 | MP0001545_abnormal_hematopoietic_system | 1.38168464 |
| 37 | MP0005397_hematopoietic_system_phenotyp | 1.38168464 |
| 38 | MP0003221_abnormal_cardiomyocyte_apopto | 1.37663715 |
| 39 | MP0003806_abnormal_nucleotide_metabolis | 1.36269646 |
| 40 | MP0000703_abnormal_thymus_morphology | 1.36177259 |
| 41 | MP0001851_eye_inflammation | 1.35805176 |
| 42 | MP0003943_abnormal_hepatobiliary_system | 1.35790626 |
| 43 | MP0002006_tumorigenesis | 1.35737466 |
| 44 | MP0003436_decreased_susceptibility_to | 1.34066171 |
| 45 | MP0000383_abnormal_hair_follicle | 1.31486370 |
| 46 | MP0010307_abnormal_tumor_latency | 1.31193248 |
| 47 | MP0004233_abnormal_muscle_weight | 1.30960462 |
| 48 | MP0002876_abnormal_thyroid_physiology | 1.26384950 |
| 49 | MP0002405_respiratory_system_inflammati | 1.26209957 |
| 50 | MP0001666_abnormal_nutrient_absorption | 1.25807140 |
| 51 | MP0002877_abnormal_melanocyte_morpholog | 1.24368471 |
| 52 | MP0001915_intracranial_hemorrhage | 1.23804295 |
| 53 | MP0005319_abnormal_enzyme/_coenzyme | 1.22457112 |
| 54 | MP0000465_gastrointestinal_hemorrhage | 1.18229418 |
| 55 | MP0001800_abnormal_humoral_immune | 1.16967336 |
| 56 | MP0005621_abnormal_cell_physiology | 1.16096388 |
| 57 | MP0002118_abnormal_lipid_homeostasis | 1.14938791 |
| 58 | MP0000015_abnormal_ear_pigmentation | 1.14023727 |
| 59 | MP0009764_decreased_sensitivity_to | 1.13892452 |
| 60 | MP0000598_abnormal_liver_morphology | 1.12670509 |
| 61 | MP0009053_abnormal_anal_canal | 1.12253370 |
| 62 | MP0001790_abnormal_immune_system | 1.11077050 |
| 63 | MP0005387_immune_system_phenotype | 1.11077050 |
| 64 | MP0005083_abnormal_biliary_tract | 1.10204142 |
| 65 | MP0003172_abnormal_lysosome_physiology | 1.08475447 |
| 66 | MP0004130_abnormal_muscle_cell | 1.07734768 |
| 67 | MP0002998_abnormal_bone_remodeling | 1.07649423 |
| 68 | MP0005671_abnormal_response_to | 1.06405063 |
| 69 | MP0000685_abnormal_immune_system | 1.05158525 |
| 70 | MP0003868_abnormal_feces_composition | 1.04903275 |
| 71 | MP0000733_abnormal_muscle_development | 1.04841918 |
| 72 | MP0005332_abnormal_amino_acid | 1.04113989 |
| 73 | MP0002086_abnormal_extraembryonic_tissu | 1.01948450 |
| 74 | MP0005666_abnormal_adipose_tissue | 1.01004080 |
| 75 | MP0003890_abnormal_embryonic-extraembry | 1.00692513 |
| 76 | MP0000858_altered_metastatic_potential | 1.00635156 |
| 77 | MP0005174_abnormal_tail_pigmentation | 1.00010634 |
| 78 | MP0002419_abnormal_innate_immunity | 0.98520318 |
| 79 | MP0004019_abnormal_vitamin_homeostasis | 0.98156301 |
| 80 | MP0009763_increased_sensitivity_to | 0.97704138 |
| 81 | MP0002332_abnormal_exercise_endurance | 0.97454317 |
| 82 | MP0003183_abnormal_peptide_metabolism | 0.96732385 |
| 83 | MP0004947_skin_inflammation | 0.96732136 |
| 84 | MP0002429_abnormal_blood_cell | 0.96151715 |
| 85 | MP0000371_diluted_coat_color | 0.95551898 |
| 86 | MP0003984_embryonic_growth_retardation | 0.93362738 |
| 87 | MP0004883_abnormal_blood_vessel | 0.92919394 |
| 88 | MP0003303_peritoneal_inflammation | 0.91600571 |
| 89 | MP0002088_abnormal_embryonic_growth/wei | 0.90911220 |
| 90 | MP0003045_fibrosis | 0.90672222 |
| 91 | MP0003453_abnormal_keratinocyte_physiol | 0.90394481 |
| 92 | MP0009115_abnormal_fat_cell | 0.90065217 |
| 93 | MP0002254_reproductive_system_inflammat | 0.89989897 |
| 94 | MP0008961_abnormal_basal_metabolism | 0.89671353 |
| 95 | MP0003077_abnormal_cell_cycle | 0.89510257 |
| 96 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.89481025 |
| 97 | MP0005275_abnormal_skin_tensile | 0.87991109 |
| 98 | MP0002009_preneoplasia | 0.87817442 |
| 99 | MP0010368_abnormal_lymphatic_system | 0.86781262 |
| 100 | MP0001533_abnormal_skeleton_physiology | 0.86678293 |
| 101 | MP0002452_abnormal_antigen_presenting | 0.86473781 |
| 102 | MP0000350_abnormal_cell_proliferation | 0.86344807 |
| 103 | MP0005164_abnormal_response_to | 0.85650755 |
| 104 | MP0010630_abnormal_cardiac_muscle | 0.83884387 |
| 105 | MP0003279_aneurysm | 0.83771433 |
| 106 | MP0000604_amyloidosis | 0.83331559 |
| 107 | MP0002796_impaired_skin_barrier | 0.82815645 |
| 108 | MP0000689_abnormal_spleen_morphology | 0.82079892 |
| 109 | MP0002148_abnormal_hypersensitivity_rea | 0.81480077 |
| 110 | MP0005375_adipose_tissue_phenotype | 0.80919581 |
| 111 | MP0002398_abnormal_bone_marrow | 0.80840526 |
| 112 | MP0003448_altered_tumor_morphology | 0.80825223 |
| 113 | MP0008469_abnormal_protein_level | 0.79378695 |
| 114 | MP0005023_abnormal_wound_healing | 0.79250884 |
| 115 | MP0005025_abnormal_response_to | 0.79026927 |
| 116 | MP0009278_abnormal_bone_marrow | 0.77955343 |
| 117 | MP0003763_abnormal_thymus_physiology | 0.77714508 |
| 118 | MP0001672_abnormal_embryogenesis/_devel | 0.77596783 |
| 119 | MP0005380_embryogenesis_phenotype | 0.77596783 |
| 120 | MP0002723_abnormal_immune_serum | 0.76885778 |
| 121 | MP0010155_abnormal_intestine_physiology | 0.76780093 |
| 122 | MP0003787_abnormal_imprinting | 0.76736272 |
| 123 | MP0005408_hypopigmentation | 0.76477293 |
| 124 | MP0009765_abnormal_xenobiotic_induced | 0.74422356 |
| 125 | MP0001819_abnormal_immune_cell | 0.74300633 |
| 126 | MP0005384_cellular_phenotype | 0.73010162 |
| 127 | MP0005310_abnormal_salivary_gland | 0.72985580 |
| 128 | MP0002420_abnormal_adaptive_immunity | 0.72091693 |
| 129 | MP0002019_abnormal_tumor_incidence | 0.71837458 |
| 130 | MP0001853_heart_inflammation | 0.71379794 |
| 131 | MP0001243_abnormal_dermal_layer | 0.71057363 |
| 132 | MP0003866_abnormal_defecation | 0.70865326 |
| 133 | MP0005000_abnormal_immune_tolerance | 0.70495424 |
| 134 | MP0003566_abnormal_cell_adhesion | 0.70482149 |
| 135 | MP0002722_abnormal_immune_system | 0.69811037 |
| 136 | MP0001216_abnormal_epidermal_layer | 0.69666517 |
| 137 | MP0003011_delayed_dark_adaptation | 0.68822508 |
| 138 | MP0003075_altered_response_to | 0.68784597 |
| 139 | MP0001845_abnormal_inflammatory_respons | 0.68065175 |
| 140 | MP0000716_abnormal_immune_system | 0.67476288 |
| 141 | MP0003091_abnormal_cell_migration | 0.67271410 |
| 142 | MP0000427_abnormal_hair_cycle | 0.66007142 |
| 143 | MP0009931_abnormal_skin_appearance | 0.64325372 |
| 144 | MP0009785_altered_susceptibility_to | 0.64290157 |
| 145 | MP0002060_abnormal_skin_morphology | 0.64128202 |
| 146 | MP0000377_abnormal_hair_follicle | 0.63570913 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 4.70298448 |
| 2 | Deep venous thrombosis (HP:0002625) | 4.69164365 |
| 3 | Complement deficiency (HP:0004431) | 4.51102503 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.40451370 |
| 5 | Abnormality of complement system (HP:0005339) | 3.56883842 |
| 6 | Abnormality of the fingertips (HP:0001211) | 3.56090658 |
| 7 | Eczematoid dermatitis (HP:0000976) | 3.53920771 |
| 8 | Joint hemorrhage (HP:0005261) | 3.50445640 |
| 9 | Prolonged partial thromboplastin time (HP:0003645) | 3.48605362 |
| 10 | Xanthomatosis (HP:0000991) | 3.33956048 |
| 11 | Hypobetalipoproteinemia (HP:0003563) | 3.29387640 |
| 12 | Spontaneous hematomas (HP:0007420) | 3.15987702 |
| 13 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.11553352 |
| 14 | Hypochromic microcytic anemia (HP:0004840) | 3.05710058 |
| 15 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.01673825 |
| 16 | Conjugated hyperbilirubinemia (HP:0002908) | 2.95248202 |
| 17 | Epidermoid cyst (HP:0200040) | 2.90611002 |
| 18 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.89481010 |
| 19 | Papillary thyroid carcinoma (HP:0002895) | 2.89096962 |
| 20 | Recurrent abscess formation (HP:0002722) | 2.87361757 |
| 21 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.87213532 |
| 22 | Hyperlipoproteinemia (HP:0010980) | 2.83940485 |
| 23 | Acute myeloid leukemia (HP:0004808) | 2.80662426 |
| 24 | Abnormality of the common coagulation pathway (HP:0010990) | 2.79451038 |
| 25 | Myocardial infarction (HP:0001658) | 2.79048077 |
| 26 | Esophageal varix (HP:0002040) | 2.76328082 |
| 27 | Systemic lupus erythematosus (HP:0002725) | 2.74920654 |
| 28 | Abnormality of methionine metabolism (HP:0010901) | 2.71364991 |
| 29 | Hepatocellular carcinoma (HP:0001402) | 2.70342768 |
| 30 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.63375230 |
| 31 | Mitral stenosis (HP:0001718) | 2.62884656 |
| 32 | T lymphocytopenia (HP:0005403) | 2.61071175 |
| 33 | Panhypogammaglobulinemia (HP:0003139) | 2.58418778 |
| 34 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.58241243 |
| 35 | Gingivitis (HP:0000230) | 2.56764081 |
| 36 | Ankyloglossia (HP:0010296) | 2.54101297 |
| 37 | Hypercholesterolemia (HP:0003124) | 2.52896415 |
| 38 | Recurrent viral infections (HP:0004429) | 2.50203980 |
| 39 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.49553579 |
| 40 | Deep philtrum (HP:0002002) | 2.49439650 |
| 41 | Hypolipoproteinemia (HP:0010981) | 2.47005895 |
| 42 | Gingival bleeding (HP:0000225) | 2.46083605 |
| 43 | Hypoplasia of the thymus (HP:0000778) | 2.43743343 |
| 44 | Bile duct proliferation (HP:0001408) | 2.43735007 |
| 45 | Abnormal biliary tract physiology (HP:0012439) | 2.43735007 |
| 46 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.42292382 |
| 47 | Osteolytic defects of the hand bones (HP:0009699) | 2.42292382 |
| 48 | Hematochezia (HP:0002573) | 2.36023725 |
| 49 | Hepatitis (HP:0012115) | 2.33971869 |
| 50 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.33823240 |
| 51 | Viral hepatitis (HP:0006562) | 2.31175188 |
| 52 | Hypoalphalipoproteinemia (HP:0003233) | 2.30331108 |
| 53 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.29553621 |
| 54 | Cellulitis (HP:0100658) | 2.26670388 |
| 55 | Glomerulonephritis (HP:0000099) | 2.26309431 |
| 56 | Dislocated radial head (HP:0003083) | 2.26222961 |
| 57 | Volvulus (HP:0002580) | 2.26068534 |
| 58 | Abnormality of oral frenula (HP:0000190) | 2.24226191 |
| 59 | Asymmetry of the thorax (HP:0001555) | 2.23805209 |
| 60 | Subacute progressive viral hepatitis (HP:0006572) | 2.20219621 |
| 61 | Acanthocytosis (HP:0001927) | 2.19741249 |
| 62 | Autoimmune thrombocytopenia (HP:0001973) | 2.15300240 |
| 63 | Fair hair (HP:0002286) | 2.14387798 |
| 64 | Slow saccadic eye movements (HP:0000514) | 2.12995082 |
| 65 | Neonatal hypoglycemia (HP:0001998) | 2.12429464 |
| 66 | Broad face (HP:0000283) | 2.11205179 |
| 67 | Flat acetabular roof (HP:0003180) | 2.09159170 |
| 68 | Recurrent fungal infections (HP:0002841) | 2.08892324 |
| 69 | Overgrowth (HP:0001548) | 2.06832554 |
| 70 | Hypochromic anemia (HP:0001931) | 2.04637676 |
| 71 | Heterotopia (HP:0002282) | 2.04009264 |
| 72 | Gastrointestinal infarctions (HP:0005244) | 2.03942117 |
| 73 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.02766694 |
| 74 | Subaortic stenosis (HP:0001682) | 2.02766694 |
| 75 | Abnormality of the radial head (HP:0003995) | 2.01395569 |
| 76 | Arterial tortuosity (HP:0005116) | 2.00835987 |
| 77 | Fat malabsorption (HP:0002630) | 2.00800010 |
| 78 | Absent frontal sinuses (HP:0002688) | 1.99662038 |
| 79 | Orchitis (HP:0100796) | 1.98107141 |
| 80 | Macroorchidism (HP:0000053) | 1.97813630 |
| 81 | Fatigue (HP:0012378) | 1.97770228 |
| 82 | Thrombophlebitis (HP:0004418) | 1.97682275 |
| 83 | Sandal gap (HP:0001852) | 1.96933743 |
| 84 | Narrow palate (HP:0000189) | 1.96150471 |
| 85 | Myositis (HP:0100614) | 1.95667706 |
| 86 | Spinal cord lesions (HP:0100561) | 1.95445144 |
| 87 | Syringomyelia (HP:0003396) | 1.95445144 |
| 88 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.95398907 |
| 89 | Chronic hepatic failure (HP:0100626) | 1.95370567 |
| 90 | Thyroiditis (HP:0100646) | 1.95242966 |
| 91 | Arterial thrombosis (HP:0004420) | 1.95163097 |
| 92 | Increased IgE level (HP:0003212) | 1.94684351 |
| 93 | Spontaneous abortion (HP:0005268) | 1.93702888 |
| 94 | Inflammation of the large intestine (HP:0002037) | 1.92690242 |
| 95 | Colitis (HP:0002583) | 1.91452318 |
| 96 | Periodontitis (HP:0000704) | 1.90330390 |
| 97 | Abnormality of the intrinsic pathway (HP:0010989) | 1.89830125 |
| 98 | Prominent nose (HP:0000448) | 1.89451535 |
| 99 | Mediastinal lymphadenopathy (HP:0100721) | 1.89245757 |
| 100 | Optic neuritis (HP:0100653) | 1.89238615 |
| 101 | Retrobulbar optic neuritis (HP:0100654) | 1.89238615 |
| 102 | Agammaglobulinemia (HP:0004432) | 1.88942917 |
| 103 | Gastrointestinal inflammation (HP:0004386) | 1.88848712 |
| 104 | Interstitial pulmonary disease (HP:0006530) | 1.88381292 |
| 105 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.87563671 |
| 106 | Skin nodule (HP:0200036) | 1.87410102 |
| 107 | Pulmonary embolism (HP:0002204) | 1.86062561 |
| 108 | Persistence of primary teeth (HP:0006335) | 1.86017092 |
| 109 | Aortic aneurysm (HP:0004942) | 1.85659245 |
| 110 | Truncal obesity (HP:0001956) | 1.85584549 |
| 111 | Recurrent bacterial skin infections (HP:0005406) | 1.84751652 |
| 112 | Abnormality of macrophages (HP:0004311) | 1.84428674 |
| 113 | Hyperammonemia (HP:0001987) | 1.83138215 |
| 114 | Difficulty running (HP:0009046) | 1.82618406 |
| 115 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.82050229 |
| 116 | Distal lower limb amyotrophy (HP:0008944) | 1.81820668 |
| 117 | Ketosis (HP:0001946) | 1.81078571 |
| 118 | Relative macrocephaly (HP:0004482) | 1.79076703 |
| 119 | Urethral obstruction (HP:0000796) | 1.78086907 |
| 120 | Recurrent cutaneous fungal infections (HP:0011370) | 1.77864927 |
| 121 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.77864927 |
| 122 | Alopecia of scalp (HP:0002293) | 1.77012230 |
| 123 | Mitral valve prolapse (HP:0001634) | 1.76029623 |
| 124 | Osteomyelitis (HP:0002754) | 1.75000841 |
| 125 | Curly hair (HP:0002212) | 1.74958573 |
| 126 | Autoimmune hemolytic anemia (HP:0001890) | 1.74729840 |
| 127 | Germ cell neoplasia (HP:0100728) | 1.74441973 |
| 128 | Low anterior hairline (HP:0000294) | 1.74372476 |
| 129 | Nephritis (HP:0000123) | 1.74114614 |
| 130 | Chest pain (HP:0100749) | 1.73963045 |
| 131 | Micronodular cirrhosis (HP:0001413) | 1.73411082 |
| 132 | Sparse lateral eyebrow (HP:0005338) | 1.72747116 |
| 133 | Thick nail (HP:0001805) | 1.72244709 |
| 134 | Spastic diplegia (HP:0001264) | 1.70150815 |
| 135 | Vertebral arch anomaly (HP:0008438) | 1.70080020 |
| 136 | Neoplasm of the liver (HP:0002896) | 1.69981588 |
| 137 | Epistaxis (HP:0000421) | 1.68432205 |
| 138 | Amyloidosis (HP:0011034) | 1.68047914 |
| 139 | Vascular tortuosity (HP:0004948) | 1.67972738 |
| 140 | Dilatation of the ascending aorta (HP:0005111) | 1.67731470 |
| 141 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.67480896 |
| 142 | Portal hypertension (HP:0001409) | 1.67462781 |
| 143 | Eosinophilia (HP:0001880) | 1.67279818 |
| 144 | Peritonitis (HP:0002586) | 1.66766563 |
| 145 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.66511951 |
| 146 | Increased connective tissue (HP:0009025) | 1.66104592 |
| 147 | Cubitus valgus (HP:0002967) | 1.65726008 |
| 148 | Bladder neoplasm (HP:0009725) | 1.65598396 |
| 149 | Keratoconjunctivitis sicca (HP:0001097) | 1.65057770 |
| 150 | Conjunctival telangiectasia (HP:0000524) | 1.64865754 |
| 151 | Generalized hypopigmentation of hair (HP:0011358) | 1.64582421 |
| 152 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.64014544 |
| 153 | Abnormality of the peritoneum (HP:0002585) | 1.63996838 |
| 154 | Cystic hygroma (HP:0000476) | 1.63988147 |
| 155 | Hyperglycinemia (HP:0002154) | 1.63932974 |
| 156 | Recurrent skin infections (HP:0001581) | 1.62944657 |
| 157 | Agnosia (HP:0010524) | 1.62463617 |
| 158 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.62305658 |
| 159 | Thyroid carcinoma (HP:0002890) | 1.60693562 |
| 160 | Long eyelashes (HP:0000527) | 1.59698660 |
| 161 | Coarse hair (HP:0002208) | 1.59408833 |
| 162 | Vascular calcification (HP:0004934) | 1.58168303 |
| 163 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.57420165 |
| 164 | Leiomyosarcoma (HP:0100243) | 1.56795261 |
| 165 | Abnormality of the hepatic vasculature (HP:0006707) | 1.54659462 |
| 166 | Spondylolisthesis (HP:0003302) | 1.54271337 |
| 167 | Abnormality of T cell number (HP:0011839) | 1.54098215 |
| 168 | Abnormal platelet volume (HP:0011876) | 1.54024546 |
| 169 | Dysmetric saccades (HP:0000641) | 1.52670588 |
| 170 | Short 4th metacarpal (HP:0010044) | 1.52349280 |
| 171 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.52349280 |
| 172 | Obsessive-compulsive behavior (HP:0000722) | 1.51577961 |
| 173 | Hyperbilirubinemia (HP:0002904) | 1.51242943 |
| 174 | Bladder carcinoma (HP:0002862) | 1.50800091 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK1 | 3.52937947 |
| 2 | FRK | 3.17639464 |
| 3 | PRPF4B | 2.93621819 |
| 4 | STK3 | 2.82663262 |
| 5 | MAP3K14 | 2.81656587 |
| 6 | CDK12 | 2.58402103 |
| 7 | TRIB3 | 2.49389036 |
| 8 | INSRR | 2.09703046 |
| 9 | BLK | 2.01753512 |
| 10 | PIK3CA | 1.99328781 |
| 11 | STK10 | 1.96882035 |
| 12 | LATS1 | 1.91974011 |
| 13 | SGK2 | 1.90999344 |
| 14 | SGK3 | 1.86418446 |
| 15 | CDK6 | 1.84554498 |
| 16 | TYK2 | 1.82154876 |
| 17 | ZAK | 1.81853232 |
| 18 | ICK | 1.81695944 |
| 19 | TAOK3 | 1.70726855 |
| 20 | TTN | 1.63744377 |
| 21 | MAP2K3 | 1.63407776 |
| 22 | FGFR2 | 1.51272852 |
| 23 | STK24 | 1.45495894 |
| 24 | IRAK4 | 1.44570867 |
| 25 | TAOK1 | 1.43770189 |
| 26 | CAMK1D | 1.41851955 |
| 27 | BMPR2 | 1.40936386 |
| 28 | MAPK7 | 1.37576797 |
| 29 | NUAK1 | 1.35624393 |
| 30 | SIK1 | 1.35334138 |
| 31 | PTK6 | 1.35041987 |
| 32 | WNK1 | 1.34281309 |
| 33 | MARK2 | 1.33853890 |
| 34 | MAP3K6 | 1.33808052 |
| 35 | KSR2 | 1.32924205 |
| 36 | MAP3K10 | 1.31663680 |
| 37 | PKN2 | 1.29594817 |
| 38 | SCYL2 | 1.29231450 |
| 39 | ERN1 | 1.24453927 |
| 40 | FGFR3 | 1.23683797 |
| 41 | ZAP70 | 1.23405687 |
| 42 | FES | 1.18059529 |
| 43 | CDK4 | 1.17168026 |
| 44 | CHUK | 1.16949671 |
| 45 | BRD4 | 1.14567913 |
| 46 | PDGFRA | 1.14339491 |
| 47 | SIK2 | 1.14254505 |
| 48 | MAP3K3 | 1.14135390 |
| 49 | MAP4K1 | 1.13006366 |
| 50 | PIK3CG | 1.11269227 |
| 51 | FLT3 | 1.10995323 |
| 52 | RIPK4 | 1.09243693 |
| 53 | NEK9 | 1.07205476 |
| 54 | JAK1 | 1.06364634 |
| 55 | MAP3K1 | 1.05697461 |
| 56 | AKT3 | 1.05587155 |
| 57 | FGFR4 | 1.04492923 |
| 58 | TAOK2 | 1.03988720 |
| 59 | SIK3 | 1.03850841 |
| 60 | NEK6 | 1.02946691 |
| 61 | PIM1 | 1.02781754 |
| 62 | TGFBR2 | 1.02047436 |
| 63 | CAMK1G | 0.98709349 |
| 64 | EEF2K | 0.98397974 |
| 65 | SMG1 | 0.96600443 |
| 66 | CSF1R | 0.95816835 |
| 67 | IKBKB | 0.95542957 |
| 68 | JAK3 | 0.94751790 |
| 69 | GRK6 | 0.91946943 |
| 70 | KIT | 0.90163484 |
| 71 | TBK1 | 0.89846859 |
| 72 | FGR | 0.89660634 |
| 73 | STK4 | 0.89287337 |
| 74 | MAPK11 | 0.88864563 |
| 75 | SGK223 | 0.88861025 |
| 76 | SGK494 | 0.88861025 |
| 77 | DAPK2 | 0.87610768 |
| 78 | TEC | 0.87340403 |
| 79 | RPS6KB2 | 0.86241893 |
| 80 | IKBKE | 0.84107911 |
| 81 | HCK | 0.83281702 |
| 82 | MST1R | 0.82312232 |
| 83 | MAP3K7 | 0.81685805 |
| 84 | MAP2K4 | 0.81591279 |
| 85 | JAK2 | 0.78643092 |
| 86 | IRAK1 | 0.77532044 |
| 87 | TTK | 0.75737929 |
| 88 | EPHB1 | 0.75042158 |
| 89 | IRAK2 | 0.74703457 |
| 90 | IRAK3 | 0.73862550 |
| 91 | KSR1 | 0.73805110 |
| 92 | TXK | 0.72430997 |
| 93 | RAF1 | 0.72336685 |
| 94 | SGK1 | 0.71316605 |
| 95 | CLK1 | 0.70196515 |
| 96 | MAP3K5 | 0.69549563 |
| 97 | MAP3K13 | 0.67503123 |
| 98 | PDGFRB | 0.67203502 |
| 99 | MTOR | 0.66997951 |
| 100 | CDC42BPA | 0.65191973 |
| 101 | HIPK2 | 0.64939391 |
| 102 | STK38 | 0.63144901 |
| 103 | CDK9 | 0.62632751 |
| 104 | MELK | 0.62512352 |
| 105 | LRRK2 | 0.62075123 |
| 106 | PDK1 | 0.60733461 |
| 107 | BTK | 0.60487177 |
| 108 | CSK | 0.57651949 |
| 109 | STK11 | 0.56105185 |
| 110 | MATK | 0.54966088 |
| 111 | PDPK1 | 0.54786321 |
| 112 | ITK | 0.53102739 |
| 113 | MAPK4 | 0.51972667 |
| 114 | PRKAA2 | 0.51645988 |
| 115 | ERBB4 | 0.50455960 |
| 116 | DMPK | 0.50052117 |
| 117 | NLK | 0.49313742 |
| 118 | RPS6KB1 | 0.48102684 |
| 119 | EGFR | 0.46952045 |
| 120 | PRKCQ | 0.46935147 |
| 121 | MAP3K2 | 0.46367257 |
| 122 | LYN | 0.45885519 |
| 123 | PTK2 | 0.45865728 |
| 124 | MAPK10 | 0.43704684 |
| 125 | YES1 | 0.43091896 |
| 126 | ATR | 0.42462379 |
| 127 | PLK2 | 0.41689614 |
| 128 | TRPM7 | 0.40870982 |
| 129 | RET | 0.40718876 |
| 130 | LCK | 0.39997314 |
| 131 | ATM | 0.39597828 |
| 132 | BMX | 0.37711255 |
| 133 | SYK | 0.37342697 |
| 134 | CAMK4 | 0.36679563 |
| 135 | MAPK1 | 0.36465339 |
| 136 | MAPK14 | 0.35878137 |
| 137 | MARK3 | 0.35773528 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.86315631 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.72302596 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.68245594 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.04184944 |
| 5 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.97867945 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.64333444 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.54442487 |
| 8 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 2.47929112 |
| 9 | Bile secretion_Homo sapiens_hsa04976 | 1.99912730 |
| 10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.97173305 |
| 11 | Lysine degradation_Homo sapiens_hsa00310 | 1.93358347 |
| 12 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.86419216 |
| 13 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.77511502 |
| 14 | ABC transporters_Homo sapiens_hsa02010 | 1.66665886 |
| 15 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.66120914 |
| 16 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.59400846 |
| 17 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.57861729 |
| 18 | Thyroid cancer_Homo sapiens_hsa05216 | 1.55114825 |
| 19 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.49670365 |
| 20 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.48748582 |
| 21 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.46585802 |
| 22 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.42725553 |
| 23 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.42201709 |
| 24 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.40870757 |
| 25 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.40597373 |
| 26 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.38396699 |
| 27 | Colorectal cancer_Homo sapiens_hsa05210 | 1.34767374 |
| 28 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.31079926 |
| 29 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.26193899 |
| 30 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.26167327 |
| 31 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.23826315 |
| 32 | Peroxisome_Homo sapiens_hsa04146 | 1.23680909 |
| 33 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.19570028 |
| 34 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.19268044 |
| 35 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.14684536 |
| 36 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.14047009 |
| 37 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.12615764 |
| 38 | Retinol metabolism_Homo sapiens_hsa00830 | 1.11972519 |
| 39 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.11713356 |
| 40 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.09259933 |
| 41 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.08538028 |
| 42 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.08054499 |
| 43 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.05563572 |
| 44 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.03313179 |
| 45 | Malaria_Homo sapiens_hsa05144 | 1.00424271 |
| 46 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.96747042 |
| 47 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.95298386 |
| 48 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.94915900 |
| 49 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.94283525 |
| 50 | Bladder cancer_Homo sapiens_hsa05219 | 0.94151903 |
| 51 | Focal adhesion_Homo sapiens_hsa04510 | 0.94005986 |
| 52 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.93651864 |
| 53 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.93439683 |
| 54 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.93047677 |
| 55 | Histidine metabolism_Homo sapiens_hsa00340 | 0.88408914 |
| 56 | Amoebiasis_Homo sapiens_hsa05146 | 0.87775848 |
| 57 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.87026891 |
| 58 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.86971988 |
| 59 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.86779260 |
| 60 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.85074596 |
| 61 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.83624271 |
| 62 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.82519002 |
| 63 | Other glycan degradation_Homo sapiens_hsa00511 | 0.82335988 |
| 64 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.81918856 |
| 65 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.81903938 |
| 66 | Legionellosis_Homo sapiens_hsa05134 | 0.81521231 |
| 67 | HTLV-I infection_Homo sapiens_hsa05166 | 0.81216243 |
| 68 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.81070281 |
| 69 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.80562057 |
| 70 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.80210549 |
| 71 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.78718076 |
| 72 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.78138826 |
| 73 | Leishmaniasis_Homo sapiens_hsa05140 | 0.77918789 |
| 74 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.77634728 |
| 75 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.77405466 |
| 76 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.75002577 |
| 77 | Insulin resistance_Homo sapiens_hsa04931 | 0.74971852 |
| 78 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.74323785 |
| 79 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.72685104 |
| 80 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.72284295 |
| 81 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.71070430 |
| 82 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.70814474 |
| 83 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.69700421 |
| 84 | Pathways in cancer_Homo sapiens_hsa05200 | 0.69449181 |
| 85 | Long-term potentiation_Homo sapiens_hsa04720 | 0.66604235 |
| 86 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.65953940 |
| 87 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.64366139 |
| 88 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.64358993 |
| 89 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.64294621 |
| 90 | Shigellosis_Homo sapiens_hsa05131 | 0.63859418 |
| 91 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.63121103 |
| 92 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.62974207 |
| 93 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.62943988 |
| 94 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.62217379 |
| 95 | Circadian rhythm_Homo sapiens_hsa04710 | 0.62210219 |
| 96 | Alcoholism_Homo sapiens_hsa05034 | 0.61825532 |
| 97 | Viral myocarditis_Homo sapiens_hsa05416 | 0.61085717 |
| 98 | Cell cycle_Homo sapiens_hsa04110 | 0.59803750 |
| 99 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.58718566 |
| 100 | Melanoma_Homo sapiens_hsa05218 | 0.58180860 |
| 101 | Endocytosis_Homo sapiens_hsa04144 | 0.56279005 |
| 102 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.55974948 |
| 103 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.55508195 |
| 104 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.55497351 |
| 105 | Salmonella infection_Homo sapiens_hsa05132 | 0.54951194 |
| 106 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.54342289 |
| 107 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.54316743 |
| 108 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.54310117 |
| 109 | Hepatitis C_Homo sapiens_hsa05160 | 0.53700048 |
| 110 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.52407742 |
| 111 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.52189250 |
| 112 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.51253114 |
| 113 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.50781192 |
| 114 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.48987509 |
| 115 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.48936638 |
| 116 | Hepatitis B_Homo sapiens_hsa05161 | 0.48865179 |
| 117 | Measles_Homo sapiens_hsa05162 | 0.48704700 |
| 118 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.47367167 |
| 119 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.47203477 |
| 120 | Influenza A_Homo sapiens_hsa05164 | 0.46378385 |
| 121 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.44339284 |
| 122 | Glioma_Homo sapiens_hsa05214 | 0.44234735 |
| 123 | Adherens junction_Homo sapiens_hsa04520 | 0.43399242 |
| 124 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.43095193 |
| 125 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.41005488 |
| 126 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.40726026 |
| 127 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.40582031 |
| 128 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.40502155 |
| 129 | Endometrial cancer_Homo sapiens_hsa05213 | 0.38731676 |
| 130 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.38461495 |
| 131 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.37903749 |
| 132 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.37351563 |
| 133 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.36551177 |
| 134 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.36293468 |
| 135 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.36208859 |
| 136 | Platelet activation_Homo sapiens_hsa04611 | 0.35474221 |
| 137 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.35448762 |
| 138 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.35106465 |
| 139 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.34832447 |
| 140 | Apoptosis_Homo sapiens_hsa04210 | 0.34698510 |
| 141 | Pertussis_Homo sapiens_hsa05133 | 0.34279775 |
| 142 | Tuberculosis_Homo sapiens_hsa05152 | 0.34269626 |
| 143 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.33720155 |
| 144 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.33444425 |
| 145 | Prostate cancer_Homo sapiens_hsa05215 | 0.32022389 |
| 146 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.31675346 |
| 147 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.31659005 |
| 148 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.31297828 |
| 149 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.31101901 |
| 150 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.30986117 |
| 151 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.30838950 |
| 152 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.29280990 |
| 153 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.28501496 |

